Literature DB >> 35788538

Pancreas and Adverse Drug Reactions: A Literature Review.

Konrad Sosnowski1, Piotr Nehring1, Adam Przybyłkowski2.   

Abstract

Adverse drug reactions (ADRs) affecting the pancreas are a heterogeneous group of side effects that cause damage to pancreatic cells. Various mechanisms such as hypersensitization, sphincter of Oddi constriction, direct cytotoxic and metabolic effects on pancreatic cells, and dose-dependent idiosyncrasy lead to intrapancreatic activation of pancreatic enzymes resulting in drug-induced acute pancreatitis. Several medications have been linked with the development of pancreatic cancer. Pancreatic cancer may result from proinflammatory, proliferative, and antiapoptotic effects. Diabetogenic effect of drugs, which is understood as impairment of insulin secretion, may occur due to direct destruction of β cells, systemic toxicity affecting pancreatic islets and cell membrane glucose transporters, induction of Th1-type autoimmune response, and impairment of voltage-gated calcium channels in β cells, endoplasmic reticulum stress, and insulin signaling. A better understanding of ADRs that affect the pancreas may contribute to improving the awareness of clinicians and patients and reducing potential harmful side effects of implemented therapies.
© 2022. The Author(s), under exclusive licence to Springer Nature Switzerland AG.

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 35788538     DOI: 10.1007/s40264-022-01204-0

Source DB:  PubMed          Journal:  Drug Saf        ISSN: 0114-5916            Impact factor:   5.228


  107 in total

1.  Mechanisms of exocrine pancreatic toxicity induced by oral treatment with 2,3,7,8-tetrachlorodibenzo-p-dioxin in female Harlan Sprague-Dawley Rats.

Authors:  Katsuhiko Yoshizawa; Tiwanda Marsh; Julie F Foley; Bo Cai; Shyamal Peddada; Nigel J Walker; Abraham Nyska
Journal:  Toxicol Sci       Date:  2005-02-16       Impact factor: 4.849

2.  A brief history of drug reactions.

Authors:  S Laughlin; R Jackson
Journal:  Clin Dermatol       Date:  1986 Jan-Mar       Impact factor: 3.541

3.  Spontaneous reports on drug-induced pancreatitis in Denmark from 1968 to 1999.

Authors:  V Andersen; J Sonne; M Andersen
Journal:  Eur J Clin Pharmacol       Date:  2001-09       Impact factor: 2.953

Review 4.  Pathophysiology of acute pancreatitis.

Authors:  Madhav Bhatia; Fei Ling Wong; Yang Cao; Hon Yen Lau; Jiali Huang; Padmam Puneet; Lakshmi Chevali
Journal:  Pancreatology       Date:  2005-04-21       Impact factor: 3.996

5.  Species differences in the distribution of drug-metabolizing enzymes in the pancreas.

Authors:  Alexis B Ulrich; Jens Standop; Bruno M Schmied; Matthias B Schneider; Terence A Lawson; Parviz M Pour
Journal:  Toxicol Pathol       Date:  2002 Mar-Apr       Impact factor: 1.902

6.  Identification of novel peptide safety markers for exocrine pancreatic toxicity induced by cyanohydroxybutene.

Authors:  Jennie L Walgren; Michael D Mitchell; Laurence O Whiteley; David C Thompson
Journal:  Toxicol Sci       Date:  2006-12-14       Impact factor: 4.849

7.  Classification of acute pancreatitis--2012: revision of the Atlanta classification and definitions by international consensus.

Authors:  Peter A Banks; Thomas L Bollen; Christos Dervenis; Hein G Gooszen; Colin D Johnson; Michael G Sarr; Gregory G Tsiotos; Santhi Swaroop Vege
Journal:  Gut       Date:  2012-10-25       Impact factor: 23.059

8.  New model of acute necrotizing pancreatitis induced by excessive doses of arginine in rats.

Authors:  S Tani; H Itoh; Y Okabayashi; T Nakamura; M Fujii; T Fujisawa; M Koide; M Otsuki
Journal:  Dig Dis Sci       Date:  1990-03       Impact factor: 3.199

9.  Hyperamylasemia and acute pancreatitis following anticholinesterase poisoning.

Authors:  Surjit Singh; Udaybhan Bhardwaj; Suresh K Verma; Ashish Bhalla; Kirandip Gill
Journal:  Hum Exp Toxicol       Date:  2007-06       Impact factor: 2.903

10.  Drug induced acute pancreatitis: incidence and severity.

Authors:  P G Lankisch; M Dröge; F Gottesleben
Journal:  Gut       Date:  1995-10       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.